SARS-CoV-2 vaccination and phase 1 cancer clinical trials

2021-03-01

The Lancet Oncology , Volume 22 - Issue 3 p. 298- 301

Additional Metadata
Persistent URL	doi.org/10.1016/S1470-2045(21)00017-6, hdl.handle.net/1765/135267
Journal	The Lancet Oncology
Organisation	Department of Medical Oncology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Yap, T.A. (Timothy A), Siu, R., Calvo, E. (Emiliano), Lolkema, M., LoRusso, P.M. (Patricia M), Soria, J. C., … Banerji, U. (2021). SARS-CoV-2 vaccination and phase 1 cancer clinical trials. The Lancet Oncology (Vol. 22, pp. 298–301). doi:10.1016/S1470-2045(21)00017-6

Publication